Economic Evaluation of Pertuzumab In Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment of Women with HER2-Positive, Locally Advanced, Inflammatory or Early Breast Cancer in Portugal
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2231
https://www.valueinhealthjournal.com/article/S1098-3015(16)33597-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2115
First Page :
A736
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33597-5&doi=10.1016/j.jval.2016.09.2231